Precision Medicine Used in New Type 2 Diabetes Study
Everybody agrees that without medical research we would not have the wide array of treatments and medications that are available to us today. One of the most recent developments is encompassed by the phrase 'precision medicine' which the Scottish Government has just invested 4 million pounds in. So what exactly does precision medicine mean and what impact is it going to make to us as individuals?
Precision medicine explores the link between a person's biological makeup (DNA), with health and disease which means that new treatments can be tailored to the individual characteristic of each patient. We are all made differently which means we react to medicines in different ways.
A recent study involving researchers from the University of Dundee, has revealed how our genetics play a vital role in how people react to a specific Type 2 Diabetes drug. Metformin is the most commonly used drug for the treatment of Type 2 Diabetes worldwide and has been for over 50 years. During this time it has been found that it works better with some people than in others, and now we may know why this is.
The researchers from both Dundee and the University of California have identified a genetic variant that affects how Metformin works in some people. With this discovery it means that researchers are closer to finding a personalised targeted treatment for Type 2 Diabetes.
To read more about the findings of this study then click here. This study is another great example of the work that is being carried out every day by allowing SHARE to utilise any leftover blood samples. To register for SHARE click here and you can follow us on Facebook, Twitter and LinkedIn.